Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ADALIMUMAB 40MG/0.8ML INJECTN (CDM PHAR07553) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 20, 2026 , from http://ppman.hank.ai/transparency/procedure/PHAR07553/by-state?code_type=CDM
“ADALIMUMAB 40MG/0.8ML INJECTN (CDM PHAR07553) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/PHAR07553/by-state?code_type=CDM. Accessed
October 20, 2026 .
“ADALIMUMAB 40MG/0.8ML INJECTN (CDM PHAR07553) by State,” HANK Price Transparency ,
accessed October 20, 2026 ,
http://ppman.hank.ai/transparency/procedure/PHAR07553/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
PHAR07553 — Adalimumab 40mg/0.8ml Injectn
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$6,571
National median
$5,914 – $6,571
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for PHAR07553 (CDM), with interquartile range
State Median p25 p75
IL $6,571 $5,914 $6,571